SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-021133
Filing Date
2017-04-20
Accepted
2017-04-20 06:31:34
Documents
1
Period of Report
2017-01-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v464469_4.html 4  
1 OWNERSHIP DOCUMENT v464469_4.xml 4 4540
  Complete submission text file 0001144204-17-021133.txt   6031
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Issuer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O DIPEXIUM PHARMACEUTICALS, LLC 74 BROAD STREET NEW YORK NY 10004
Business Address
Shawah Robert G. (Reporting) CIK: 0001601121 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36351 | Film No.: 17771328